IGWM
DAWN

ICA Group Wealth Management’s Day One Biopharmaceuticals DAWN Stock Holding History

ICA Group Wealth Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$6.75K Buy
490
+455
+1,300% +$6.66K ﹤0.01% 541
2024
Q1 		$578 Buy
+35
New +$524 ﹤0.01% 1288

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ICA Group Wealth Management's DAWN Position: Q2 2024 in Review

ICA Group Wealth Management increased its Day One Biopharmaceuticals (DAWN) stake by 1,300% in Q2 2024, buying an estimated $6.66K and bringing the position to 490 shares worth $6.75K. The position accounts for ﹤0.01% of the portfolio, ranked #541.

ICA Group Wealth Management first reported a position in DAWN in Q1 2024 and has held it in 2 quarters since. 156 funds tracked by Wall St. Rank hold DAWN as of Q2 2024.

  • ICA Group Wealth Management held 490 shares of Day One Biopharmaceuticals worth $6.75K as of Q2 2024.
  • ICA Group Wealth Management bought 455 Day One Biopharmaceuticals shares in Q2 2024, an estimated $6.66K.
  • Day One Biopharmaceuticals made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #541 holding.
  • ICA Group Wealth Management first reported a position in Day One Biopharmaceuticals in Q1 2024 and has held it in 2 quarters since.
  • 156 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.